Catalyst4, Inc.
5 of 6 shown
The 5 most recent of 6 visible filings, newest first.
- MapLight Therapeutics, Inc. 10% owner$33,328,154Open-market buy
- MapLight Therapeutics, Inc. 10% owner$50,072,000Open-market buy
- MapLight Therapeutics, Inc. 10% owner$13,000,000Open-market buy
- MapLight Therapeutics, Inc. 10% owner$37,890Open-market buy
- MapLight Therapeutics, Inc. 10% owner$761,393Open-market buy